Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Eylea Industry?

In the past few years, robust growth has been observed in the Eylea market size. The projected growth is from $9.94 billion in 2024 to an estimated $10.51 billion by 2025, representing a compound annual growth rate (CAGR) of 5.7%. Factors contributing to this progressive growth during the historic period are attributable to the widespread prevalence of diabetic macular edema (DME), the clinical effectiveness and safety profiles, competition posed by other anti-VEGF therapies, approvals for a variety of retinal conditions, and a shift towards the use of intravitreal injections.

In the approaching years, the eylea market is predicted to witness robust growth, escalating to $13.64 billion in 2029 with a compound annual growth rate (CAGR) of 6.7%. This growth during the prediction period can be ascribed to factors such as rising therapeutic indications, the arrival of biosimilar competition, enhanced awareness and diagnosis, real-world validation and post-market research, and a patient preference for less frequent injections. Key trends for the forecast period comprise advancements in imaging technologies, the rise of telemedicine and remote tracking, patient assistance plans, advancements in drug delivery innovations, retinal imaging technologies, and clinical trials for novel indications.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9155&type=smp

#Which Factors Are Currently Driving The Growth Of The Eylea Market?

The escalating incidence of eye diseases is predicted to drive the Eylea market. Eye diseases, which impede the eye’s capacity to function correctly and adversely impact vision and eye clarity, are becoming increasingly common. These conditions often go undetected until they are significantly progressed. Eylea is used to manage eye diseases like wet age-related macular degeneration (AMD) and glaucoma, both of which damage the retina or macula, affecting sight. Eylea functions by blocking the protein that forms new, weaker blood vessels, and reducing swelling in the retina induced by blood vessel blockage. To illustrate, in October 2022, the BrightFocus Foundation, an American nonprofit organization committed to promoting research and support for macular degeneration and glaucoma, reported that there were 80 million people globally suffering from glaucoma. These numbers are expected to rise to over 111 million by 2040. Consequently, this upsurge in eye diseases is fueling the Eylea market.

How Is The Global Eylea Market Structured In Terms Of Segments?

The eylea market covered in this report is segmented –

1) By Product: Prefilled Syringe Package, Vial Package

2) By Disorder: Wet Age-Related Macular Degeneration (AMD), Diabetic Retinopathy, Other Disorders

3) By Application: Hospitals, Retail Pharmacy, Other Applications

Subsegments:

1) By Prefilled Syringe Package: Single-Dose Prefilled Syringes, Multi-Dose Prefilled Syringes

2) By Vial Package: Single-Dose Vials, Multi-Dose Vials

What Trends Are Currently Influencing Growth In The Eylea Market?

Innovations and research have emerged as pivotal trends in the eylea market. Big players in the sector are heavily investing in avant-garde technical advancements. Taking an example, in August 2023, Regeneron Pharmaceuticals, Inc., a biotechnology company stationed in the US and dedicated to medicine creation for critical diseases, won US FDA nod for Eylea HD (aflibercept) injection 8 mg. This new advancement aims to cater to patients suffering from ailments like wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and diabetic retinopathy (DR). The routine administration includes an initial span of every four weeks for the first three months for all indications, followed by alterations to every eight to 16 weeks for wAMD and DME, and every eight to 12 weeks for diabetic retinopathy.

Who Are The Main Participants Shaping The Eylea Market Landscape?

Major companies operating in the eylea market include Regeneron Pharmaceuticals Inc., Bayer AG, Novartis AG, Roche Holding AG, Pfizer Inc., Amgen Inc., Sanofi S.A., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Biogen Inc., Alcon Inc., Johnson & Johnson, Eli Lilly and Company, Genentech Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Samsung Bioepis Co. Ltd., Lupin Limited, Sun Pharmaceutical Industries Ltd., Zydus Cadila, Torrent Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals LLC, Apotex Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/eylea-global-market-report

Which Region Currently Holds The Largest Share In The Eylea Market?

North America was the largest region in the eylea market in 2024. Asia-Pacific is expected to be the fastest-growing region in the eylea market during the forecast period. The regions covered in the eylea market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9155&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model